2-(Phenylsulfonyl)aniline

We are 2-(Phenylsulfonyl)aniline CAS:4273-98-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-(Phenylsulfonyl)aniline
CAS.NO:4273-98-7
Synonyms:2-(Phenylsulfonyl)aniline
2-(benzenesulfonyl)aniline
2-Aminophenyl Phenyl Sulfone
Benzenamine, 2-(phenylsulfonyl)-
2-Aminodiphenyl Sulfone
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 439.6±28.0 °C at 760 mmHg
Melting Point 120-122 °C(lit.)
Molecular Formula C12H11NO2S
Molecular Weight 233.286
Flash Point 219.7±24.0 °C
 
Specification:
Appearance:Off-white to tan crystalline powder
Assay(Titration):≥98.0%
Aniline:≤0.5%
OCA:≤1.0%
2-Nitro Diphenyl Sulfone:≤0.5%
Other Impurities:≤2.0%
Methanol:≤0.1%
1-Butanol:≤0.1%
Insoluble:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Dye intermediate,for example, it can synthesize acid yellow 246、61、25 and acid red 42

2-(Phenylsulfonyl)aniline


Related News: According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.59004-18-1 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.7472-43-7 Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%.1188-21-2 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.

Related Products
Product Name
2-Methylsulfonyl-4,6-dimethoxypyrimidine View Details
pyridin-2-ol View Details
benzyl isothiocyanate View Details
2,3-dihydro-1H-inden-2-amine manufacturer Furfuryl thioacetate manufacturer (2S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile manufacturer N-Methyl-1,2-benzenediamine dihydrochloride manufacturer 1-Bromo-3-fluoro-2-nitrobenzene manufacturer